FDA Monitoring 20 Drugs at Risk of Shortage due to Coronavirus
As part of its efforts to ensure the supply of medical products from China during the ongoing coronavirus (COVID-19) outbreak, the US Food and Drug Administration (FDA) has identified 20 drugs that are made in or produced solely from active pharmaceutical ingredients (APIs) sourced from China. In a statement to Focus, FDA spokesperson Stephanie Caccomo said…